Coronavirus
The Absence of Long COVID Treatment Plans Has Become a New Business Opportunity for Medium-sized Pharmas
2022-03-30
Mu COVID Variant Could Potentially Escape Immunity But Delta is Still “Most Concerning”, WHO Says
2021-09-08
Monoclonal Antibodies for COVID-19: AstraZeneca and Regeneron’s Therapies Endure Contrasting Fortunes
2021-06-16
COVID-19: Rise in UK Cases Trigger Global Concerns Over “Highly Infectious” Delta Variant
2021-06-14
India’s COVID Crisis Roundup: Eli Lilly Collaborates with 3 Local Drugmakers to Upscale Baricitinib
2021-05-11